C12N 2770/16034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/16034 (Use of virus or viral component as vaccine) appears on 102 US grants and 157 published applications in this corpus.
Search patents in C12N- Granted patents
- 102
- Published applications
- 157
- Assignees
- 85
- Inventors
- 279
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 1 |
| 2003 | 2 | 2 |
| 2004 | 1 | 5 |
| 2005 | 2 | 5 |
| 2006 | 1 | 2 |
| 2007 | 3 | 4 |
| 2008 | 2 | 6 |
| 2009 | 5 | 3 |
| 2010 | 2 | 7 |
| 2011 | 4 | 9 |
| 2012 | 3 | 6 |
| 2013 | 4 | 11 |
| 2014 | 4 | 7 |
| 2015 | 2 | 3 |
| 2016 | 7 | 9 |
| 2017 | 4 | 1 |
| 2018 | 7 | 6 |
| 2019 | 5 | 4 |
| 2020 | 4 | 11 |
| 2021 | 3 | 7 |
| 2022 | 5 | 9 |
| 2023 | 10 | 12 |
| 2024 | 4 | 13 |
| 2025 | 6 | 10 |
| 2026 | 4 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Combined norovirus and rotavirus vaccine composition and methods of preparation31 Mar 2026US 12,589,144 B2Bharat Biotech International Limited
- Norovirus S particle based vaccines and methods of making and using same3 Feb 2026US 12,539,327 B2Children's Hospital Medical Center
- Artificial RNA molecules encoding a norovirus antigen and uses thereof20 Jan 2026US 12,527,856 B2CureVac AG
- Nucleic acid molecules and uses thereof6 Jan 2026US 12,514,918 B2CureVac AG
- Rabbit haemorrhagic disease virus (RHDV) vaccines23 Dec 2025US 12,503,493 B2
- Recombinant expression vector for production of virus-like particle-based multivalent norovirus vaccine and manufacturing method therefor24 Sep 2026US 2026/0284173 A1Inthera Inc.
- Norovirus mrna vaccines10 Sep 2026US 2026/0263582 A1ModernaTX, Inc.
- Porcine sapovirus isolates and immunogenic compositions therefrom2 Jul 2026US 2026/0183379 A1Iowa State University Research Foundation, Inc.
- Nucleic acid molecules and uses thereof21 May 2026US 2026/0137769 A1CureVac AG
- Nucleic acid molecules and uses thereof28 Aug 2025US 2025/0269007 A1CureVac AG
Most cited
By later US patents
- Viral adjuvants48US 7,862,829 B2The University of North Carolina at Chapel Hill · 2011
- Norovirus and Sapovirus antigens35US 7,527,801 B2Novartis Vaccines and Diagnostics, Inc. · 2009
- Artificial nucleic acid molecules encoding a norovirus antigen and uses thereof30US 11,141,474 B2CureVac AG · 2021
- Norovirus vaccine formulations29US 7,955,603 B2Ligocyte Pharmaceuticals, Inc. · 2011
- Methods for producing norovirus VLPS26US 8,119,145 B2Novartis Vaccines and Diagnostics, Inc. · 2012